FIELD: experimental medicine.
SUBSTANCE: invention relates to experimental medicine, namely to obstetrics and gynecology, and can be used for the treatment of polycystic ovary syndrome (PCOS) in an experimental model of Wistar rats. The method consists in the fact that on the model of drug-induced polycystic ovary syndrome using letrozole at a dosage of 800 mcg/day or 400 mcg /day for 60 days, oral administration of natural phytoalexin resveratrol is performed at a dosage of 30 mg/kg/day or 20 mg/day. kg/day for 30 days.
EFFECT: invention helps to restore the estrous cycle, reduce body weight, reduce cystic changes, increase the layer of granular cells, as well as the appearance of oocytes.
1 cl, 1 ex, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING POLYCYSTIC OVARY SYNDROME | 2020 |
|
RU2757220C1 |
| METHOD FOR TREATING CHRONIC ANOVULATION AND PREVENTING SYNDROME OF OVARIAN HYPERSTIMULATION | 1999 |
|
RU2201225C2 |
| METHOD OF ASSESSING OF AROMATASE ACTIVITY OF OVARIAN FOLLICLES | 2015 |
|
RU2602456C1 |
| METHOD FOR TREATMENT OF POLYCYSTIC OVARY SYNDROME ASSOCIATED WITH METABOLIC SYNDROME | 2020 |
|
RU2749783C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS OF METFORMIN AND/OR WEIGHT-LOSS THERAPY IN PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME | 2010 |
|
RU2427842C1 |
| TREATMENT OF HEPATIC STEATOSIS RELATED OLIGO-OVULATION | 2016 |
|
RU2745606C2 |
| METHOD OF DIAGNOSTIC ANOVULATION | 2016 |
|
RU2650627C1 |
| METHOD FOR MODELING POLYCYSTIC OVARIES AT PREDOMINANCE OF FOLLICULAR CYSTS | 2005 |
|
RU2282249C1 |
| METHOD FOR OVARIES ANTRAL FOLLICLES AROMATASE ACTIVITY ASSESSMENT | 2016 |
|
RU2619345C1 |
| METHOD OF MODELLING OF POLYCYSTIC OVARIES | 2007 |
|
RU2337411C1 |
